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Summary.-Ehrlich ascites tumours (EAT) were grown in mice by injecting 1 x 106
cells intraperitoneally. In mice which received one or more injections of 30 mg
soybean trypsin inhibitor (TI) i.p. during tumour growth, the number of recoverable
tumour cells was significantly reduced by up to 92%. Also, the mean size of these
cells was significantly smaller.
When the rate of labelled thymidine incorporation in vitro was compared in TI-
treated and control cells, no significant differences were detected. However, when
the population doubling time of EAT cells in vivo was calculated, it was apparent that
recoverable TI-treated cells were dividing more rapidly than controls. Consequently,
the reduced number of cells recovered from TI-treated mice did not result from a
reduced growth rate.
Viability, assessed by trypan blue dye exclusion and rate of labelled chromium
release, was the same in TI-treated and control cell populations. Thus TI was non-
toxic to EAT cells and the reduced number of cells from treated tumours was not
therefore due to cytotoxicity.
Scanning electron microscopy revealed that normal EAT cells did not adhere to
internal host surfaces but that after TI treatment they adhered in lar e numbers to
produce an appearance which resembled a confluent monolayer. This binding to
host tissue accounted for the reduction in the number of cells recovered from TI-
treated animals. We propose that TI acts as a protease inhibitor topreventintrinsic
proteolytic enzyme activity at the tumour cell surface. This activity would normally
destroy the binding sites required for adhesion to host tissue.
PLANTagglutininssuchas concanavalin
A (Con A) bind to carbohydrates at cell
surfaces (Winzler, 1970). Cells whichhave
undergone malignant transformation are
agglutinated by such treatment but most
normal cells are not (Inbar and Sachs,
1969). Treatment of such untransformed
cells with proteolytic enzymes, however,
renders them agglutinable (Inbar and
Sachs, 1969; Nicolson, 1972) and Burger
(1969) proposed that the changes in cell
membrane architecture produced by pro-
teases were the same as those resulting
from malignant transformation. He sub-
sequently correlated these surface changes
with a loss of growth control in normal
cells, by demonstrating a temporary loss
of contact inhibition after trypsin treat-
ment (Burger, 1970). Burger and Noonan
(1970) subsequently reported the restora-
tion of contact inhibition to polyoma-
transformed 3T3 cells by coating them
with a non-agglutinating Con A prepara-
tion obtained by trypsin digestion. On
the basis of this evidence, we postulated
that the abnormal growth characteristics
of malignant cell populations in vivo may
result from the same cell surface altera-
tions which characterize transformed or
protease treated cells in vitro, and which
result in a loss of contact inhibition. We
therefore attempted to establish some
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degree of growth control in Ehrlich
ascites tumours (EAT) by modifying the
cell surface in the manner described by
Burger and Noonan (1970). Doses of
1 mg " monovalent " Con A (Burger and
Noonan, 1970) were injected intraperi-
toneally (i.p.) on alternate days into mice
carrying EAT. By Day 11 this had resulted
in a mean total recoverable tumour cell
population size of 148 x 106 cells, com-
pared with 527 x 106 cells in the un-
treated group. However, another control
group which had received injections of
soybean trypsin inhibitor (TI), since
this was a component of the Con A
preparation, had a mean recover-
able tumour size of only 57 x 106 cells.
Consequently the reduction in the number
offree tumour cells was attributable to the
presence of TI and not to Con A. This
paper reports a series of experiments
which investigate the reasons for the
reduction in the number of tumour cells
recoverable from TI-treated animals.
These experiments show that the effect is
attributable to the adhesion of the cells to
the tissues of the host. The results
suggest that TI achieves this effect by
inhibiting proteolytic activity at the
tumour cell surface.
MATERIALS AND METHODS
Ehrlich ascites tumour analysis.-This
tumour has been maintained in our laboratory
by routine weekly passage of 1 x 106 cells
injected i.p. into 30 g male TO mice (Tucks,
Rayleigh, U.K.). These cells show no
tendency to aggregate in vivo and almost no
tendency to adhere to the internal surfaces
ofthe abdominal cavity. In order to examine
the growth of tumours after treatment with
TI, mice were injected with 1 x 106 tumour
cells i.p. On alternate days thereafter they
received up to 30 mg of lyophilized, chroma-
tographically prepared TI (Type I-s, Sigma,
St Louis, U.S.A.) i.p., dissolved in sterile
phosphate buffered saline (Flow, Irvine,
U.K.). Control groups received injections of
the saline only. To recover the tumour the
mice were anaesthetized with ether, killed
and the ascites cells removed in saline.
Calculations of total number and size distri-
bution analysis wvere carried out on each
tumour using a model Fn Coulter counter
(Coulter, Dunstable, U.K.). Cell samples
were diluted with "' Isoton " before counting
through a 100 ,um orifice. For total counts
the machine was set at aperture = 128,
attenuation= 2, and threshold = 5. Cell
size distribution analysis was carried out
using the same settings, with a threshold
window width of 5 over the range 5-100.
These readings were converted to Hm3 after
calibrating the machine against polystyrene
latex balls of 9.7 /tm and 16-6 jum diameter.
Estimations ofthe DNA content of cells were
performed in conjunction with cell size
analyses as just described. After counting,
cells were extracted twice with ice cold 5%
perchloric acid, twice with a defatting solvent
(ether: ethanol: chloroform, 2: 2: 1 v/v/v),
and suspended in 500 perchloric acid at 70°C
for 15 min. The supernatant solution ob-
tained was estimated for DNA content by the
diphenylamine method (Burton, 1956).
Non-tumour cell analysis. To investigate
the normal cell population in the peritoneal
cavity of non tumour-bearing mice, cells
were removed in saline and counted using the
Coulter counter settings described above.
Rates of DNA synthesis.-Three different
types of experiment were undertaken to
determine the rates of DNA synthesis in
tumour cell populations using the rate of
uptake of thymidine (methyl-H3) (1.5 mCi/
mouse; sp. act. 18-4 Ci/mmol) or thymidine-
2-C14 (1-14-2-5 ,uCi/ml; sp. act. 53-59 mCi/
mmol) (Radiochemical Centre, Amersham,
U.K.). For in vitro experiments cells were
washed 3 times in ice cold phosphate buffered
saline (Flow). Initially, rates of uptake in
tumour cells treated with TI in vivo were
compared with untreated control cells. In
subsequent experiments untreated tumour
cells were preincubated in TI (5 mg/ml) for
1 hour in vitro before incubation in labelled
thymidine. In both types of experiment,
cells were incubated with labelled thymidine
for several hours and the specific activity of
TCA precipitates was then determined using
methods described by Whur and Weather-
head (1971). In the third type ofexperiment
a single tumour cell population was heavily
labelled in vivo with twice daily injections of
250 ,uCi 3H labelled thymidine for a period of
3 days. Thiswasfollowedbya cold thymidine
chase, consisting of 1000 times the total
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amount of labelled thymidine administered,
given as a single i.p. injection. After 24 hours
the labelled cells were recovered, washed, and
single doses of 1 x 106 cells were injected
into 2 groups of mice. The next day one
group received 30 mg of TI, the other saline
only. The cells were recovered after 72 hours
in vivo and the amount of thymidine label
per cell was compared in the 2 groups, using
the same methods as before.
Cell viability experiments.-Cell viability
was assessed both by trypan blue dye exclu-
sion and by monitoring labelled chromium
release. In the case of trypan blue, a few
drops of freshly harvested unwashed cells
were mixed with a 0.10% solution of the dye.
Two hundred cells were then examined from
each tumour, using a haemacytometer slide,
and viability was expressed as the mean
percentage ofunstained cells. For chromium
release experiments, washed cells were sus-
pended at 1 x 106/ml in Eagle's minimal
essential medium (Biocult, Paisley, U.K.) and
incubated for 1 hour at 37TC in the presence
of 4 ,ul/ml of 51Cr solution (aqueous sodium
chromate, 6 ,ug Cr/ml, 1-03 mCi/ml, Radio-
chemical Centre, Amersham, U.K.). They
were then washed in 4 changes of medium
and incubated for a further 3 hours in fresh
medium, after which time 51Cr release was
measured by incorporating an aliquot of the
cell-free medium into scintillation fluid. The
cells were then killed by heating to 60TC for
20 min to determine total releasable radio-
activity (Pickaver et al., 1972).
Scanning electron microscopy.-In order to
observe the degree to which cells had adhered
to intra-abdominal surfaces, a square of
ventral abdominal wall was removed from
tumour bearing mice, washed in cold phos-
phate buffered saline and fixed at 4°C in
2.5% glutaraldehyde. After immersion in
several changes of buffered wash, samples
were frozen in isopentane, cooled with liquid
N2 and freeze dried at -20 to -40TC. After
mounting on stubs, the samples were coated
with gold palladium and examined in a
Stereoscan microscope (Cambridge Instru-
ments, Cambridge, U.K.). These observa-
tions were repeated on 5 separate occasions.
Statistical methods.-All experimental
groups initially contained 25 animals and
means are based on these groups. Variation
is expressed as standard error ofthe mean and
Student's 't' test was used to detect signi-
ficance between different samples at P <0-05.
RESULTS
Effect of TI on the number of recoverable
tumour cells
Four groups of mice were given
1 x 106 tumour cells on Day 0 and were
subsequently injected i.p. with 0, 1, 5, or
20 mg of TI in 0-5 ml of saline on Day 1
and alternate days thereafter. The mice
were killed on Day 10 and the total
number of recoverable cells and cell size
distribution ofthe 4 groups were compared
(Fig. 1). When compared with the un-
treated control, there was a significant
reduction in the mean cell number (P
<0-01) and size (P <0-005) only in that
group which had received doses of 20 mg
of TI. We subsequently adopted a stan-
dard dose rate of 30 mg of TI given on
alternate days for all experiments. After
8 days of tumour growth the mean total
number of tumour cells recovered from
mice which had received TI was reduced
by 92% (P< 0-001) when compared with
the yield from control mice (Fig. 2).
Cells from treated mice were also signi-
ficantly smaller (P <0-001).
Having established that TI caused a
major reduction in the number and size of
recoverable tumour cells after 8 days of
tumour growth, we investigated its effect
on cell populations after shorter periods of
tumour growth. Even when mice were
killed on Day 2, after only a single injec-
tion of TI (Fig. 3), there was a significant
reduction in the mean total number of
recoverable cells (P <0-02) and in their
size (P <0-01). A feature not previously
observed was the presence of 2 separate
peaks in the cell size distribution of the
untreated control group (Fig. 3). The
single peak in the TI-treated group
coincided with the smaller, 270 Um3,
control group peak. This finding can be
interpreted in 2 ways. Firstly, there may
be 2 distinct cell populations, comprising
predominantly tumour cells in control
mice and smaller non-tumour cells of host
origin in TI-treated mice. Alternatively,
the smaller size of cells recovered from TI
treated mice may be an effect of TI on the
tumour cell population. In view of these
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FIG. 1. Effect of injecting TI i.p. on alternate days on the mean total number and size ofrecoverable
EAT cells. Mice received 1 x 106 tumour cells on Day 0 and were killed on Day 10. The total
area of each curve corresponcls to the total number of tumour cells recovered and a shift to the
left indicates a reduction in their mean cell size. El Control animals injected with saline.
Cells recovered (822 + 66) x 106. Mean cell size 757 ± 240 ,um3. * 1 mg TI on alternate
days. Cells recovered (1006 ± 159) x 106. Mean cell size 596 ± 164 /lm3. * 5 mg TI. Cells
recovered (530 ± 91) x 106. Mean cell size 673 ± 198 ,um3. A 20 mg TI. Cells recovered
(282 ± 76) X 106. Mean cell size 470 + 149 ,um3.
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FIG. 2. Effect of TI on the niumber and size of recoverable tumour cells after 8 days of growth.
O Control animals injected with saline. Cells recovered (357 ± 44) x 106. Mean cell size 683
± 323 4m3. U 30 mg TI i.p. on alternate days. Cells recovered (28 ± 11) x 106. Mean cell
size 498 ± 103 jum3.
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FIG. 3. Effect of a single injection of TI on the number and size of recoverable cells after 2 days of
growth. C- Control animals injected with saline. Cells recovered (8 ± 1) x 106. Mean cell
size 726 ± 232 jUm3. * 30 mg TI i.p. on alternate days. Cells recovered (2 ± 1) x 106. Mean
cell size 585 ± 238 ,um3.
possibilities, an experiment was designed
to compare mean population and cell
sizes oftumours originating from the same
number of either treated or untreated
tumour cells. Firstly, the mean number
and size of recoverable cells were com-
pared from tumours of mice injected with
TI and untreated controls killed on Day 8
(Fig. 4a). Predictably, the effect of the
TI was to reduce significantly both the
mean total number (P <0 02) and size
(P <0 02) of the recoverable cells. Ali-
quots of 1 x 106 cells of either population
were then injected into 2 groups of fresh
mice and the tumours were allowed to
grow for 5 days without further treatment.
On Day 5 the tumours from each group
had become indistinguishable in respect of
mean total number (P >0 9) and size
(P >0 9) (Fig. 4b), indicating that the
recoverable cells from TI-treated and
control animals formed a single homo-
geneous population.
In order to establish how long the
double peak observed in untreated controls
on Day 2 (Fig. 3) persisted, a further
experiment was carried out in which
animals were killed on Day 4. By this
time, the size distribution of cells in
control animals had reverted to the single
670 jUm3 peak observed at later times
(Fig. 5). There were significant differences
between the groups in respect ofmeantotal
number ofrecoverable cells (P <0 05) and
their size (P <0-01).
Since it wAas a constant feature ofthese
experiments that the mean size of cells
recovered from TI-treated mice was signi-
ficantly less than that from controls, this
change in size was investigated by deter-
mining the mean DNA content per cell in
these 2 groups on Day 4 (Table I). Whilst
TABLE I. -Size and DNA Content of
EAT Cells Recovered front Mice after
4 Days of Growth
Cells from untreated
controls
Cells from TI-treated
animals
Cell size
(Gim8)
950± 87
,tg DNA/cell
(X 106)
16- 574-0 63
625±106 17-89±1-27
P <0-05 P >0 5
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FIG. 4. (a) Effect of TI on the number and size of recoverable cells after 8 days of tumour growth.
H] Control animals injected with saline. Cells recovered (395 ± 96) x 106. Mean cell size
709 322 jzm3. * 30mg TI i.p. on alternate days. Cells recovered (42 ± 11) x 106. Mean
cell size 499 ± 206 ,um3. (b) Effect on the number and size of recoverable cells after 5 days of
tumour growth in mice injected with 1 x 106 cells recovered from TI-treated or control mice.
Mice receiving cells from control animals. Cells recovered (57 ± 24) x 106. Mean cell size
709 ± 349 M3. * Mice receiving cells from TI-treated animals. Cells recovered (74 30) x 106.
Mean cell size 715 325 _M3.
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FIG. 5.-Effect of TI on the number and size of recoverable tumour cells after 4 days of growth.
D Control animals injected with saline. Cells recovered (65 ± 9) x 106. Mean cell size 768 ± 492
,um3. * 30 mg TI i.p. on alternate days. Cells recovered (36 ± 12) x 106. Mean cell size
403 ± 278 ,um3.
the mean cell size of the TI-treated group
was again lower than that of the control
group (P <0 05), there was no significant
difference in DNA content per cell between
the groups (P >0 5).
Effect of TI on normal peritoneal cell
population
Six hours after i.p. injection of 30 mg
of TI into non tumour-bearing mice, the
size of the peritoneal cell population
recovered in saline was not significantly
different from that of control mice (P
>0 5) (Table II).
TABLE II. The Size of the Normal Peri-
toneal Cell Population in Non Tumour-
bearing Mice 6 Hours after i.p. Injection
of TI or Saline
Initial level
After i.p. injection of saline
After i.p. injection of TI
Cell couint
(X 10-4)
654- 0 ± 73 * 0
529-8±95-7
410* 2 ±80* 7
Effect of TI on the rate of cell division
When cells were removed from TI-
treated and control mice, washed and
their in vitro rates of 14C labelled thymi-
dine uptake compared, no significant
differences were detected. Since this
result might have been influenced by the
absence ofTI from theincubationmedium,
we resorted to in vitro preincubation of
untreated cells with TI before labelling
with thymidine. Again, however, no
statistical differences were detected al-
though the experiment was repeated a
number of times. We therefore examined
the doubling time of the cell population
tn vivo. For this purpose a group of
tumour cells was labelled in vivo with
thymidine over a 2-day growth period.
These cells were then recovered and
reinjected into 2 groups of mice, one of
which received a single dose of TI on the
following day. The cells were harvested
on the third day after injection and the
TCA-precipitable radioactivity per cell
was calculated. There was a significant
difference in the level of labelling of the
two cell populations (Table III). Assum-
ing that growth was exponential, cells in
the untreated control mice underwent 4
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£ IG. f.- canning EiMV micrograph of the internal surface of mouse abdominal wall 21 hours after the injection of 1 x 108 EAT cells. There are virtually no cells adhering to the surface. x approx. 400.
rIG. 7.nThe internal abdominal surface of a mouseinjected 21 hourspreviously with 1 X 107 tumour cells, followed immediately by 30 mg of TI. The tumour cells have adhered to the host's tissue as a monolayer. x approx. 400.
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TABLE III. 3H-thyrnidine Levels i'
Prelabelled EAT Cells after 72 Hour6
in vivo. The Level of Labelling id
Expressed as the TCA-precipitable Radio-
activity per 1 X 107Cells
d/min ts.e.
mean P
Initial level (0 hour) 35220±7030
After 72 hours in control mice 2410+320 0*OO
After 72 hours in TI-treated 940±220 <
mice
cell divisions compared with 5 in the TI-
treated group; this represents doubling
times of 18 and 14 hours respectively.
Toxicity of TI to EAT cells
Since the smaller number of cells
recovered from TI-treated tumours was
not the result of a slower growth rate, we
examined the possibility that it was due
to cytotoxicity. As measured by trypan
blue dye exclusion, there were no more
dead cells present in the TI-treated
populations than in the controls (Table
IV). This observation assumes that dead
TABLE IV.-Viability of EAT Cells Re-
covered from Mice after 8 Days of
Growth, Using the Trypan Blue Dye
Exclusion Test. Viability is Expressed
as the Percentage of Cells Excluding the
Dye
Cells from untreated controls
Cells from TI-treated animals
Viability ± s.e.
mean
98 4±0 9
99- 1 ±0 3
cells persist long enough for them to be
present in detectable numbers; we there-
fore monitored the release of 51Cr from
prelabelled cells during in vitro incubation
with TI and compared this with control
cells. There was no detectable difference
in the rates of release from the 2 groups
(Table V). The evidence suggests, there-
fore, that at the concentrations used TI
is nontoxic to EAT cells.
Scanningl electron microscope observations
The experiments described above show
that the observed reduction in the number
TABLE V.-Release of 5'Crfrom Prelabelled
EAT Cells after Incubationfor 3 Hours in
vitro. Total Releasable Radioactivity is
Expressed as the Sum of Counts Released
into the Supernatant during Incubation
Plus Additional Radioactivity Released
when Cells were Heat Killed
Total
releasable Released P
(ct/min±s.e. (ct/min±s.e.
mean) mean)
TI added to medium 1850 ± 9t 465 _ 23
at 5 mg/ml >0 3
Control 1725±108 541±22
of recoverable tumour cells from TI-
treated animals could not be explained by
a reduction in the total tumour cell popu-
lation. Wetherefore examined the internal
abdominal surfaces of TI-treated and
control mice to see if tumour cells were
being retained by the host as the result of
injections of TI. When the ventral
abdominal wall was examined we found,
21 hours after tumour injection, that
virtually no cells adhered to this surface in
control animals (Fig. 6), even when
1 x 108 cells were injected. However, in
animals which received 30 mg of TI
immediately after the injection of tumour
cells, large numbers ofthe cells adhered to
the host's tissues (Fig. 7). The cells
appeared to form a monolayer; in no
instance did we recognize ascites cells
adhering to each other. Adherent cells
were characterized by processes extending
from their basal surface and ramifying
over the adjacent host surface.
DISCUSSION
Effect of TI on the number and size of
recoverable tumour cells
Groups of mice injected i.p. with EAT
cells and subsequently i.p. with either TI
in saline or saline alone on alternate days,
were compared in respect of the total
number of recoverable cells at different
periods over the next 10 days. There was
consistently a statistically significant re-
duction in the yield from the TI-treated
groups (Fig. 1-5). Cell size distribution
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analysis indicated that this reduction was
not attributable to tumour cells aggre-
gating in vivo. Even in groups of mice
killed on Day 2 after a single injection of
TI (Fig. 3) there was a reduction of 7500
in the number of recoverable cells. This
reduction was not attributable to a TI-
induced initial lag phase inthegrowthrate,
since the mean rate of cell division during
the first 72 hours following transplantation
was significantly greater in TI-treated
than in control cell populations (Table III).
There was also a significant difference
in the mean size of control cells (700-800
1Im3) compared with TI-treated cells
(400-600 pm3). After 2 days of tumour
growth and a single injection of TI, the
treated group showed a single peak at
270 jUm3, whereas the untreated control
cells showed 2 peaks (Fig. 3). By Day 4
the controls peaked only at 670 11m3
whereas the treated group persisted at
270 ,um3 (Fig. 5) and this subsequently
remained unchanged. When such cells
were injected in equal amounts into fresh
mice they produced recoverable cell popu-
lations which were identical both in
respect of total number and mean size,
irrespective of whether they originated
from TI-treated or control mice (Fig.
4a,b). Thus the 2 populations are com-
posed of similar cells, the difference in size
being attributable to the action of TI.
This difference in size is not, however,
clearly correlated with a change in DNA
content (Table I). It cannot therefore be
attributable to the change in size which is
seen in EAT and other tumour cells as a
consequence of the reduced ploidy result-
ing from the increased growth rate which
follows tumour transplantation (Basleer
and Desaive, 1971; Dombernowsky, Bichel
and Hartmann, 1973). It must therefore
be due to a decrease in the mean volume
ofcytoplasm, probably as the result ofthe
increased growth rate of TI-treated cells.
Effect ofTI on the growth rate oftumour cells
It seemed reasonable to suppose that
the considerable reduction in the number
of recoverable tumour cells produced by
treatment with TI was the result of a
reduced growth rate. However, whensuch
cells were removed from treated mice and
compared with untreated control cells in
respect of their relative rates of labelled
thymidine incorporation in vitro, no differ-
ence between the 2 groups could be
detected. This did not, however, eliminate
the possibility that the cells might rapidly
revert to the normal rate of growth if TI
was removed from the medium or from the
cell surface during the washing and dilu-
tion procedures associated with this series
of experiments. We therefore modified
the design, using hitherto untreated
tumour cells which were preincubated in
vitro with TI before comparing the rate of
thymidine incorporation with that of
untreated control cells. Again, however,
no significant differences were observed.
In order to reflect more accurately the
conditions in vivo, we used a population
of cells whose DNA had been prelabelled
with 3H-thymidine, to observe the
decline in the level of labelling per cell
when grown in TI-treated or control mice.
Cells recovered from TI-treated mice
contained a significantly lower level of
label and were therefore undergoing mito-
sis at more frequent intervals (Table III).
Since analysis of tumour cell kinetics in
control mice suggested that growth is
almost exponential for the first 10 days
after the injection of 1 x 106 tumour
cells, the figures in Table III indicate
recoverable cell population doubling times
of 14 hours for TI-treated and 18 hours for
control cells. This clearly indicates that
TI has no inhibitory effect upon mitotic
rate.
Toxicity of TI
The fact that the viability of TI-
treated cells, as judged by the exclusion of
trypan blue dye, was the same as that of
controls (Table IV) does not entirely
exclude the possibility that TI was toxic
to the cells, unless we assume that dead
cells persist for a sufficient period to
represent a statistically detectable propor-
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tion ofthe total population. This problem
was eliminated by the observation that
cells preincubated in 51Cr released label
at the same rate when incubated in vitro,
whether or not TI was added to the incu-
bation medium (Table V). On the basis
of these observations, it is apparent that
TI does not kill or lyse cells at the con-
centrations used and the reduction in the
number of cells recovered from TI-treated
mice cannot be attributed to such aneffect.
Adhesion of tumour cells to host tissues
Our line of EAT cells does not nor-
mally adhere to the internal abdominal
surfaces of the host in which it is grown
(Fig. 6). Consequently, the mean number
of cells recoverable from untreated mice
accurately reflects the actual tumour size.
When such tumours were treated with TI
the number ofcells subsequently recovered
wasmarkedlyreducedwhen comparedwith
controls. This was due to large numbers
of cells adhering to the host's tissues as a
result of TI treatment (Fig. 7) and not to
any cytotoxic effect or alteration in
growth rate. Direct evidence that the
adhering cells are indeed tumour cells is
being prepared at the moment, but present
evidence indicates that they are not
inflammatory cells. Cells from TI-treated
and control animals formed a single
homogeneous population (Fig. 4a,b), which
would not be the case if a substantial
number of cells from the TI-treated mice
were peritoneal macrophages. Further-
more, the normal peritoneal cell popula-
tion of non tumour-bearing mice was
unaltered 6 hours after TI injection
(Table II). Consequently, it is unlikely
that there is an inflammatory response to
TI, and thus the cells adhering to the
abdominal wall are most probably tumour
cells.
Whether or not such adherent cells
were undergoing subsequent cell divisions
has not yet been established. Thefact
that they appeared to form a tightly
packed monolayer (Fig. 7) might suggest
that further growth had been arrested by
contact inhibition, manifested as a result
of the TI mediated cell surface change
which caused them to adhere tohosttissue.
However, contact inhibition is normally
associated with cells grown on impene-
trable supports; in the present case it is
possible that cells invade the underlying
host tissues, and the appearance of an
apparently well ordered monolayer may
be deceptive.
The fact that TI-treated cells adhere to
host tissues is of considerable theoretical
interest and there are a number ofpossible
explanations to account for it. TI may act
as an agglutinin by forming cross-linkages
between cells which result in aggregation
(Inbar and Sachs, 1969). However, it
would have to possess two binding sites
ofdifferent specificities in order to account
for its observed failure to agglutinate the
EAT cells at the same time as it promoted
their binding to host cells. Furthermore,
although Con A binds in similar amounts
to the membranes of normal and malig-
nant cells (Ozanne and Sambrook, 1971)
it does not initiate agglutination in
untransformed cells unless the cell surface
binding sites are reorientated by proteo-
lytic activity (Nicolson, 1972). Conse-
quently, if TI forms bridges between
tumour cells and host cells it is also
necessary to postulate that the host cell
binding sites are exposed in the " re-
orientated" manner under normal con-
ditions. For these reasons it appears
extremely unlikely that TI mediates the
adhesion of tumour and host cells by such
a mechanism.
A more likely possibility is that TI
alters the surface of either the host or the
tumour cell in such a way as to complete
a system of binding sites directly linking
the two cell types. This linkage would
have a degree of specificity to account for
the failure of tumour cells to bind to each
other. The presence of TI may allow the
build up of specific binding sites on the
tumour cell surface, by inhibiting an
intrinsic protease of tumour origin which
otherwise destroys the sites. This hypo-
thesis is supported by the demonstration
that the agglutination of EAT cells by
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Con A is greatly enhanced by preincuba-
tion with TI, (Payne, Whur and Robson,
1973). Presumably Con A agglutination
sites are increased in the presence of this
protease inhibitor, in line with the finding
that the agglutination oftransformed cells
by Con A is reduced after trypsin treat-
ment (Inbar and Sachs, 1969). We
postulate, therefore, that EAT cells bind
to host tissue as a result of the inhibition
by TI of intrinsic proteolytic activity.
This hypothesis receives support from
observations which indicate that treat-
ment of malignant cells with protease
inhibitors in vitro results in an alteration
of growth characteristics, which may
result from modification ofthe cell surface
(Goetz, Weinstein and Roberts, 1972;
Schnebli and Burger, 1972). Our findings
support the view that the abnormal
growth rates and adhesive properties of
tumour cells are related to modification of
cell surface binding sites by the activity of
intrinsic proteases.
We thank Miss P. Murray for technical
assistance. We would also like to record
our appreciation to Dr D. C. Williams,
Head of the Research Department, for his
constant interest and encouragement.
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